These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 15084524

  • 1. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
    Watanabe N, Araki W, Chui DH, Makifuchi T, Ihara Y, Tabira T.
    FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
    [Abstract] [Full Text] [Related]

  • 2. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM, Herbert MK, Kleinovink JW, Kiliaan AJ, De Waal RM, Verbeek MM.
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and patients.
    Hosono-Fukao T, Ohtake-Niimi S, Hoshino H, Britschgi M, Akatsu H, Hossain MM, Nishitsuji K, van Kuppevelt TH, Kimata K, Michikawa M, Wyss-Coray T, Uchimura K.
    Am J Pathol; 2012 May; 180(5):2056-67. PubMed ID: 22429964
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM, Kuiperij HB, de Waal RM, Verbeek MM.
    J Alzheimers Dis; 2010 May; 22(2):345-55. PubMed ID: 20847441
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
    Cho HJ, Son SM, Jin SM, Hong HS, Shin DH, Kim SJ, Huh K, Mook-Jung I.
    FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
    [Abstract] [Full Text] [Related]

  • 11. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T.
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [Abstract] [Full Text] [Related]

  • 12. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.
    Snow AD, Mar H, Nochlin D, Kimata K, Kato M, Suzuki S, Hassell J, Wight TN.
    Am J Pathol; 1988 Dec; 133(3):456-63. PubMed ID: 2974240
    [Abstract] [Full Text] [Related]

  • 13. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K.
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [Abstract] [Full Text] [Related]

  • 14. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
    Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, Eckman EA, Prada C, Younkin L, Murphy P, Pinnix I, Onstead L, Sambamurti K, Golde TE, Dickson D, Younkin SG, Eckman CB.
    FASEB J; 2001 Jan; 15(1):16-18. PubMed ID: 11099491
    [Abstract] [Full Text] [Related]

  • 15. Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease.
    Shimizu H, Ghazizadeh M, Sato S, Oguro T, Kawanami O.
    J Clin Neurosci; 2009 Feb; 16(2):277-82. PubMed ID: 19091577
    [Abstract] [Full Text] [Related]

  • 16. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
    Lorenzo A, Yuan M, Zhang Z, Paganetti PA, Sturchler-Pierrat C, Staufenbiel M, Mautino J, Vigo FS, Sommer B, Yankner BA.
    Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
    [Abstract] [Full Text] [Related]

  • 17. Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.
    O'Callaghan P, Sandwall E, Li JP, Yu H, Ravid R, Guan ZZ, van Kuppevelt TH, Nilsson LN, Ingelsson M, Hyman BT, Kalimo H, Lindahl U, Lannfelt L, Zhang X.
    Brain Pathol; 2008 Oct; 18(4):548-61. PubMed ID: 18422760
    [Abstract] [Full Text] [Related]

  • 18. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG, Vieira MN, Saraiva LM, Figueroa-Villar JD, Garcia-Abreu J, Liu R, Chang L, Klein WL, Ferreira ST.
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [Abstract] [Full Text] [Related]

  • 19. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
    Snow AD, Kinsella MG, Parks E, Sekiguchi RT, Miller JD, Kimata K, Wight TN.
    Arch Biochem Biophys; 1995 Jun 20; 320(1):84-95. PubMed ID: 7793988
    [Abstract] [Full Text] [Related]

  • 20. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
    Philipson O, Lord A, Lalowski M, Soliymani R, Baumann M, Thyberg J, Bogdanovic N, Olofsson T, Tjernberg LO, Ingelsson M, Lannfelt L, Kalimo H, Nilsson LN.
    Neurobiol Aging; 2012 May 20; 33(5):1010.e1-13. PubMed ID: 22118948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.